Neurodegenerative Diseases

Research Focus

With many countries worldwide having at least 20% of their population aged over 65 years by 2030, the progressive loss of structure or function of neurons and their death – such as in Parkinson’s, Alzheimer’s, and Huntington’s diseases – represents a major clinical burden. Discovering cellular mechanisms involved in neuronal loss might offer new diagnostic and therapeutic advances.
The NIBN’s Neurodegenerative Diseases research group focuses on the development of innovative immune-modulating and peptide-based therapeutic strategies for Alzheimer’s disease, understanding defective protein-protein interactions in ALS and utilizing model systems to unveil mechanisms of neurodegeneration and assessment of naturally-occurring plant extracts to halt cell loss.